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DES Thrombosis Occurs in 2%; Risk Factors Identified, Outcomes Poor
The ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos)Study Group studied the issue of drug-eluting stent (DES) thrombosis in the real
world setting by collecting standardized data on every case of definite stent thrombosis
from 20 cardiac centers throughout Spain. There were 301 cases of definite stent
thrombosis (ST) giving a cumulative incidence of 2% at 3 years. Antiplatelet treatment
had been discontinued in 32%, 30% were late (1 to 12 months), and 21% were very
late (1 year). Independent predictors of late ST were stents placed during ST-
segment elevation myocardial infarction, stents in the left anterior descending artery,
and longer stent length. The cumulative incidence of ST after DES implantation in
routine clinical practice was 2% at 3 years; one-half of these events occurred in the first
month, but the risk for thrombosis extends much longer. See page 986.
Heart Rhythm Disorders
Electrogram Characteristics May
Define Areas Necessary for Propagating AF
Complex fractionated electrograms in left atrial tissue may identify areas that arecritical for the maintenance of atrial fibrillation (AF). Takahashi and colleagues
studied electrogram characteristics in 40 patients with chronic AF. After pulmonary
vein isolation and left atrium (LA) roof line ablation, electrogram-based ablation was
performed in the LA and coronary sinus. Termination of AF occurred in 73% of cases
during electrogram-based ablation. Characteristics of the electrograms that were asso-
ciated with AF termination included a higher percentage of continuous electrical
activity and the presence of a temporal gradient of activation. This study suggests that
smaller areas of the LA, which can be identified by electrograms, may be necessary for
the propagation of AF. Targeting these areas for ablation may increase the frequency of
success for patients with chronic AF. See page 1003.
Page 1026
Cardiac Imaging
Pattern of LGE May Diagnose Cardiac Amyloidosis
Diagnosing cardiac amyloidosis usually requires an endomyocardial biopsy(EMB), which suffers from low sensitivity if an affected area is not sampled.
Vogelsberg and colleagues performed cardiovascular magnetic resonance imaging
(CMRI) and EMB on 33 people suspected of having amyloidosis. In patients with
biopsy-proven cardiac amyloidosis, CMRI revealed a distinct pattern of late gadolin-
ium enhancement (LGE), which was distributed over the entire subendocardial cir-
cumference, extending in various degrees into the neighboring myocardium. This
pattern was found in 80% of the patients diagnosed with a positive EMB; the specificity
was 94%. In patients with biopsy-proven cardiac amyloidosis, LGE frequently occurs
in a peculiar pattern, which may be useful for making a noninvasive diagnosis, or
possibly for assessing progression of disease. See page 1022. See figure.
